These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 1200907

  • 1. Transfer factor: Potential for therapy of malignant diseases.
    Neidhart JA, LoBuglio AF.
    Arch Otolaryngol; 1975 Nov; 101(11):664-6. PubMed ID: 1200907
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Transfer factor: an overlooked potential for the prevention and treatment of infectious diseases.
    Viza D, Fudenberg HH, Palareti A, Ablashi D, De Vinci C, Pizza G.
    Folia Biol (Praha); 2013 Nov; 59(2):53-67. PubMed ID: 23746171
    [Abstract] [Full Text] [Related]

  • 4. [Transfer factor. Properties and possible therapeutic applications (author's transl)].
    Grob PJ, Reymond JF, Häcki MA, Frey-Wettstein M.
    MMW Munch Med Wochenschr; 1975 Mar 28; 117(13):517-24. PubMed ID: 805916
    [Abstract] [Full Text] [Related]

  • 5. Transfer factor: a potential agent for cancer therapy.
    LoBuglio AF, Neidhart JA.
    Med Clin North Am; 1976 May 28; 60(3):585-90. PubMed ID: 775210
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The study of human transfer factor.
    Li ZL.
    Sci Sin B; 1985 Apr 28; 28(4):394-401. PubMed ID: 4012263
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of long-term therapy with transfer factor in rheumatoid arthritis.
    Georgescu C.
    Med Interne; 1985 Apr 28; 23(2):135-40. PubMed ID: 4023587
    [Abstract] [Full Text] [Related]

  • 11. Cellular immunity in patients with the Wiskott-Aldrich syndrome before and after administration of transfer factor: a follow-up study.
    Schut BJ, Dooren LJ, Uittenbogaart CH, Schellekens PT, Eijsvoogel VP.
    Immunology; 1979 Jan 28; 36(1):1-12. PubMed ID: 369991
    [Abstract] [Full Text] [Related]

  • 12. Interstitial transfer factor as adjuvant immunotherapy for experimental glioma.
    Pineda B, Estrada-Parra S, Pedraza-Medina B, Rodriguez-Ropon A, Pérez R, Arrieta O.
    J Exp Clin Cancer Res; 2005 Dec 28; 24(4):575-83. PubMed ID: 16471320
    [Abstract] [Full Text] [Related]

  • 13. [Cell immunity responses in patients with widespread neoplasias following administration of transfer factor (author's transl)].
    Simó-Camps E, Vich JM, García Calderón PA, Bofill D, Grau A, Anguiz A, Forcadell I.
    Med Clin (Barc); 1980 May 25; 74(10):403-7. PubMed ID: 6968012
    [No Abstract] [Full Text] [Related]

  • 14. A randomized, double-blind, placebo-controlled trial of transfer factor as adjuvant therapy for malignant melanoma.
    Miller LL, Spitler LE, Allen RE, Minor DR.
    Cancer; 1988 Apr 15; 61(8):1543-9. PubMed ID: 3280114
    [Abstract] [Full Text] [Related]

  • 15. Transfer factor.
    Spitler LE.
    Int J Dermatol; 1978 Apr 15; 17(6):445-58. PubMed ID: 355164
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.